Zdenka Jonak

1.9k total citations
37 papers, 1.5k citations indexed

About

Zdenka Jonak is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Zdenka Jonak has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 16 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Zdenka Jonak's work include Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (10 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Zdenka Jonak is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (10 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Zdenka Jonak collaborates with scholars based in United States, United Kingdom and Netherlands. Zdenka Jonak's co-authors include Frank C. Barone, Robert Clark, G Feuerstein, C.J. Fish, R. F. White, William J. Price, Ray F. White, James Velier, Giora Feuerstein and Julie A. Ellison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Zdenka Jonak

37 papers receiving 1.4k citations

Peers

Zdenka Jonak

IMMUN

ONCOL

NEURO

RNMI

Laura Martínez‐Muñoz Spain

Neil Broadway United Kingdom

Mark Allegretta United States

Natalia V. Giltiay United States

Yves Chicheportiche Switzerland

Daniela Coltrini Italy

B Thoma Germany

Takeru Yoshimura Japan

Stephanie H. Kim United States

Ken Wasserman United States

Laura Martínez‐Muñoz Spain

Zdenka Jonak

1.3k ×2.3

IMMUN

710 ×1.3

853 ×2.3

ONCOL

109 ×0.4

NEURO

132 ×0.6

RNMI

Citations per year, relative to Zdenka Jonak Zdenka Jonak (= 1×) peers Laura Martínez‐Muñoz

Countries citing papers authored by Zdenka Jonak

Since Specialization

Citations

This map shows the geographic impact of Zdenka Jonak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdenka Jonak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdenka Jonak more than expected).

Fields of papers citing papers by Zdenka Jonak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdenka Jonak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdenka Jonak. The network helps show where Zdenka Jonak may publish in the future.

Co-authorship network of co-authors of Zdenka Jonak

This figure shows the co-authorship network connecting the top 25 collaborators of Zdenka Jonak. A scholar is included among the top collaborators of Zdenka Jonak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdenka Jonak. Zdenka Jonak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simpkins, Fiona, Aurea E. Flores, Christina Chu, et al.. (2013). Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study. Cancer Immunology Research. 1(3). 168–178. 41 indexed citations

Robertson, Michael J., Justin Kline, Herbert Struemper, et al.. (2013). A Dose-Escalation Study of Recombinant Human Interleukin-18 in Combination With Rituximab in Patients With Non-Hodgkin Lymphoma. Journal of Immunotherapy. 36(6). 331–341. 29 indexed citations

Srivastava, Shivani, David Y. Lewis, Zdenka Hašková, et al.. (2013). Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin. Cancer Immunology Immunotherapy. 62(6). 1073–1082. 55 indexed citations

Facciabene, Andrea, Marinos Tsiatas, Carmine Carpenito, et al.. (2011). Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy. Journal of Translational Medicine. 9(1). 77–77. 44 indexed citations

Facciabene, Andrea, Carmine Carpenito, Fabián Benencia, et al.. (2009). Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. Journal of Translational Medicine. 7(1). 104–104. 35 indexed citations

Carroll, Richard G., Carmine Carpenito, Xiaochuan Shan, et al.. (2008). Distinct Effects of IL-18 on the Engraftment and Function of Human Effector CD8+ T Cells and Regulatory T Cells. PLoS ONE. 3(9). e3289–e3289. 48 indexed citations

Herzyk, Danuta J., Jeanne M. Soos, Curtis C. Maier, et al.. (2002). IMMUNOPHARMACOLOGY OF RECOMBINANT HUMAN INTERLEUKIN-18 IN NON-HUMAN PRIMATES. Cytokine. 20(1). 38–48. 11 indexed citations

Veenstra, Korina G., et al.. (2002). IL-12 Induces Monocyte IL-18 Binding Protein Expression Via IFN-γ. The Journal of Immunology. 168(5). 2282–2287. 41 indexed citations

Jonak, Zdenka, Curtis C. Maier, Francis L. McCabe, et al.. (2002). High-Dose Recombinant Interleukin-18 Induces an Effective Th1 Immune Response to Murine MOPC-315 Plasmacytoma. Journal of Immunotherapy. 25. S20–S27. 16 indexed citations

10.

Khandekar, Sanjay S., Carol Silverman, Helen Birrell, et al.. (2001). Determination of Carbohydrate Structures N-Linked to Soluble CD154 and Characterization of the Interactions of CD40 with CD154 Expressed in Pichia pastoris and Chinese Hamster Ovary Cells. Protein Expression and Purification. 23(2). 301–310. 15 indexed citations

11.

Caliceti, Paolo, Francesco M. Veronese, & Zdenka Jonak. (1999). Immunogenic and tolerogenic properties of monomethoxypoly(ethylene glycol) conjugated proteins. Il Farmaco. 54(7). 430–437. 8 indexed citations

12.

Prabhakar, Uma, Ian E. James, Robert A. Dodds, et al.. (1998). A Novel Human Bone Marrow Stroma-Derived Cell Line TF274 Is Highly Osteogenic In Vitro and In Vivo. Calcified Tissue International. 63(3). 214–220. 21 indexed citations

13.

Owen, Judith A., et al.. (1996). Successful in vitro antigen-dependent activation of 24-hour-old peripheral blood lymphocytes. Journal of Immunological Methods. 190(1). 39–49. 1 indexed citations

14.

Prabhakar, Uma, Ian E. James, Robert A. Dodds, et al.. (1995). In vitro mineralization of a novel human stromal cell line TF-274, correlates with its ability to form bone in vivo. Bone. 17(6). 571–571. 1 indexed citations

15.

Clark, Robert, et al.. (1994). Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Research Bulletin. 35(4). 387–392. 149 indexed citations

16.

Jonak, Zdenka, et al.. (1993). A Human Lymphoid Recombinant Cell Line with Functional Human Immunodeficiency Virus Type 1 Envelope. AIDS Research and Human Retroviruses. 9(1). 23–32. 46 indexed citations

17.

Clark, Robert, C.J. Fish, R. F. White, et al.. (1993). Development of tissue damage, inflammation and resolution following stroke: An immunohistochemical and quantitative planimetric study. Brain Research Bulletin. 31(5). 565–572. 214 indexed citations

18.

Hart, T K, et al.. (1993). Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. Journal of Virology. 67(7). 3818–3825. 68 indexed citations

19.

Lillquist, Jay S., P L Simon, Murray R. Summers, Zdenka Jonak, & Peter R. Young. (1988). Structure-activity studies of human IL-1 beta with mature and truncated proteins expressed in Escherichia coli .. The Journal of Immunology. 141(6). 1975–1981. 21 indexed citations

20.

Jonak, Zdenka, Virginia Braman, & Roger H. Kennett. (1984). Production of Continuous Mouse Plasma Cell Lines by Transfection with Human Leukemia DNA. Hybridoma. 3(2). 107–118. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact